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Polyalanine repeat expansion diseases are hypothesized to result
from unequal chromosomal recombination, yet mechanistic
studies are lacking. We identified two de novo cases of hand-
foot-genital syndrome (HFGS) associated with polyalanine
expansions in HOXA13 that afforded rare opportunities to
investigate the mechanism. The first patient with HFGS was
heterozygous for a de novo nine codon polyalanine expansion.
Haplotype investigation showed that the expansion arose on the
maternally inherited chromosome but not through unequal
crossing over between homologs, leaving unequal sister chro-
matid exchange during mitosis or meiosis or slipped mispairing
as possible explanations. The asymptomatic father of the second
patient with HFGS was mosaic for a six codon polyalanine
expansion. Multiple tissue PCR and clonal analysis of paternal
fibroblasts showed only expansion/WT andWT/WT clones, and
haplotype data showed that two unaffected offspring inherited
the same paternal allele without the expansion, supporting a
postzygotic origin. Absence of the contracted allele in themosaic
father does not support sister chromatid exchange in the origin
of the expansion. Mosaicism for HOXA13 polyalanine expan-
sions may be associated with a normal phenotype, making
examination of parental DNA essential in apparently de novo
HFGS cases to predict accurate recurrence risks. We could not
find an example in the literature where unequal sister chromatid
exchange has been proven for any polyalanine expansion, sug-
gesting that the principalmechanism for polyalanine expansions
(and contractions) is slipped mispairing without repair or that
the true frequency of unequal sister chromatid exchange involv-
ing these repeats is low.  2013 Wiley Periodicals, Inc.
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INTRODUCTION
Hand-foot-genital syndrome (HFGS; OMIM 140000) is an auto-
somal dominant condition characterized by limb and urogenital
defects, including bilateral shortening of the thumbs and great toes,
vesicoureteral reflux, incomplete M€ullerian fusion in females, and
hypospadias in males [Innis, 2006]. The HFGS is caused by muta-
tions in the HOXA13 gene (OMIM 142959) [Mortlock and Innis,
1997; Goodman, 2000]. The HOXA13 gene includes two exons;
exonone contains three largepolyalanine repeat tracts of 14, 12, and
18 residues (labeled I through III for simplicity), while exon two
encodes the homeodomain. The majority of reported mutations in
the HOXA13 gene in patients with HFGS have been in-frame,
meiotically and mitotically stable, short (7–14 residue) expansions
within any one of the three large polyalanine tracts, while point
mutations comprise nearly all of the remaining mutations [Innis,
2006].
At least nine distinct diseases are associated with short poly-
alanine expansions in other genes encoded by imperfect triplet
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repeats [Brown and Brown, 2004], and recentlyNIPA1 polyalanine
expansions have been associated with earlier onset and shortened
median survival in amyotrophic lateral sclerosis [Blauw et al.,
2012]. While replication slippage and associated mechanisms
[Chen et al., 2005; Pearson et al., 2005; McMurray, 2010] have
been shown to cause the unstable contractions and expansions
associated with classic trinucleotide repeat diseases, polyalanine
expansions are hypothesized to be caused by unequal crossing-over
[Warren, 1997; Brown and Brown, 2004]; however, this has not
been proven in HOXA13 polyalanine expansion mutations in
patients with HFGS. Replication slippage or slipped mispairing
[Strand et al., 1993;Mortlock et al., 1996; Tishkoff et al., 1997; Innis
et al., 2004;Chen et al., 2005; Parodi et al., 2008;Trochet et al., 2007]
mediated by misalignment of short repetitive sequences during
replication is anothermechanismcapable of generating polyalanine
expansion (or contraction) mutations. Unequal sister chromatid
exchange or homologous recombination is not supported by the
observations of (1) polyalanine tract expansions involving at least
two duplications in single alleles of HOXD13 and FOXL2 [Brown
and Brown, 2004], (2) sequence incompatibilities with recombina-
tion in PHOX2B [Trochet et al., 2007], and (3) lack of deletion
products expected for unequal sister chromatid exchange inmosaic
patients with polyalanine expansions in PHOX2B [Trochet et al.,
2007; Parodi et al., 2008].We identified two rare cases of apparently
de novo HFGS associated with HOXA13 polyalanine expansions
allowing for experimental testing of these hypotheses.
MATERIAL AND METHODS
This study was approved by the University of Michigan Medical
Institutional Review Board. Genomic DNA was extracted from
leukocytes.
HOXA13 exons 1 and 2 were amplified by PCR using custom
oligonucleotide primer pairs designed using Primer3 as previously
described [Innis et al., 2004]. To obtain independent clones, PCR
products were ligated into the p-GEM T-Easy Vector system
(Promega Corp., Fitchburg, WI), electroporated MegaX DH10b
T1R Electrocomp cells (Invitrogen/Life Technologies Corp.,
Grand Island, NY), and blue-white colony selection was used.
We used SNPs upstream and downstream of HOXA13 and
inverse PCR to determine SNP phase on each chromosome. BstBI
restriction enzyme sites located outside of the region of interest
were utilized to cut maternal genomic DNA and re-ligate, followed
by inverse PCR to appose upstream and downstream SNPs. The
PCRproducts were gel-excised and cloned. Sequencing of 18 clones
using custom primers produced the final haplotypes (Fig. 3).
Luciferase assays were performed in NG108-15 cells comparing
HOXA13wt andHOXA13-G177Rmutant proteins. TheHOXA13-
G177R mutant construct was generated by using the QuikChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA), and the
presence of this mutation was confirmed by DNA sequencing.
NG108-15 cells (ATCC#HB-12317) were maintained in DMEM
media (Gibco/Life Technologies Corp., Grand Valley, NY) supple-
mented with 10% FBS (Atlanta Biologicals, Norcross, GA), HAT
(Invitrogen), and 1% penicillin/streptomycin. Cells (1 105)
were seeded in 12-well plates and grown for 24 hr at 378C with
5% CO2. Transfections were performed using FuGENE6 transfec-
tion reagent (Roche Applied Science, Indianapolis, IN), 0.1mg
pRL-CMV Renilla, and 0.25mg pCAGGS-HOXA13 wild type or
mutant, along with 0.5mg of a pGL4.23 plasmid (Promega) encod-
ing luciferase and containing an EphA7 cis-regulatory element
previously shown to be regulated by HOXA13 [Stadler et al.,
2001]. Empty pGL4.23 and pCAGGs expression vectors were
used as controls (red bars). The Dual-Glo Luciferase Assay system
(Promega) was used to detect luciferase activity 24 hr posttrans-
fection in OptiPlate-96F black plates using a Fusion Microplate
Analyzer (Perkin Elmer, Waltham, MA). Six replicates of each
transfection were performed and the transfection assay was repeat-
ed a total of three separate times. Results were normalized for
transfection efficiencyusing aRenilla luciferase expression vector as
described by the manufacturer (Promega). Because the pGL4.23
vector also contains several HOXA13 binding sites, background
activation of the empty pGL4.23 by HOXA13 was also subtracted
from the final luciferase levels after Renilla normalization.
CLINICAL REPORTS
Patient 1 is a female born to nonconsanguineous parents. No
pregnancy or birth history was available. The patient had a history
of normal developmental milestones. We first evaluated her at 17
years, 10 months of age. At that time, her height was 150.2
centimeters (3rd centile), her weight was 45.7 kg (5–10th centile),
and her head circumference was 54.0 cm (35th centile). The
patient’s medical history was significant for genitourinary abnor-
malities including a small bladder, urinary leakage, and multiple
urinary tract infections necessitating numerous Mitrofanoff and
bladder augmentation procedures. Additional medical history was
significant for back and heel pain, a right inguinal hernia status—
postrepair, a left heminephrectomy, and scoliosis with no thor-
acolumbar vertebral segmentation anomaly. Clinical examination
and radiographic findings showed a short distal phalanx of the
thumbs bilaterally, micronychia of the thumbs bilaterally, limited
flexion of the DIP joint and distal phalanges of the fourth fingers
bilaterally, radial fifth finger clinodactyly bilaterally, short distal
phalanges of all toes bilaterally, short middle phalanges of all toes
bilaterally, fusion of the middle and distal phalanges of all toes
bilaterally, hypoplasia of the cuneiform bilaterally with right-sided
fusion with the metatarsal, and micronychia of the great toes
bilaterally (Fig. 1A). Based on these historical and physical findings,
the patient was diagnosed with HFGS. The patient’s mother and
maternal half-sister were also examined and were unaffected
(Fig. 1B). The patient’s father is deceased but reportedly did not
have thumb, toe, or genitourinary abnormalities. A maternal half-
brother and paternal half-brother were also both reportedly unaf-
fected. Based on the family history and physical exams, we hypoth-
esized that the first patient had de novo HFGS.
Patient 2 is amale born to a 25-year-oldmother and 27-year-old
father who are nonconsanguineous. The patient was born at 39
weeks’ gestation and weighed 4.1 kg (>90th centile) and was
51.4 cm long (75–90th centile). The pregnancywas uncomplicated.
Shortly after birth, the patient was diagnosed with bacterial pneu-
monia and spent time in the neonatal intensive care unit. The
patient met expected developmental milestones. We first evaluated
him at 35 months of age. At that time, his height was 94.8
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centimeters (46th centile), hisweightwas 13.8 kg (40th centile), and
his head circumference was 49.8 cm (54th centile). Physical exami-
nation revealed several bony abnormalities of the hands and feet, as
well as partial cutaneous two-three-toe syndactyly bilaterally
(Fig. 5C,D). The patient was also found to have mild glandular
hypospadias with no history of urinary tract infections and occa-
sional toe-walking. A skeletal survey showed the following abnor-
malities: short middle phalanx of all fingers, short proximal and
distal phalanges of the thumbs, radial fifth finger clinodactyly
bilaterally, short first metacarpals bilaterally, short distal phalanges
of all toes bilaterally, short proximal phalanges of the great toes,
absent ossification of the middle phalanges of toes 2 through
5 bilaterally, and short first metatarsals. Based on these findings,
the patient was diagnosed with HFGS.
The patient’s mother, father, brother, sister, maternal
grandfather, and maternal grandmother were also examined
and were unaffected. Based on the family history and physical
exams, we hypothesized that the second patient also had de novo
HFGS.
RESULTS
Patient 1
Amplification of an exon 1 segment including the large 18 residue
polyalanine tract (III) resulted in one product compatible withwild
type length (arrow, Fig. 2A) and a larger amplicon. Sequencing of
independent clones from several independent amplifications
showed one allele with a nine-alanine expansion in tract III
(c.357_383 dup27, Fig. 2B) and, surprisingly, a second allele
with a point mutation, c.529G>C (p.Gly177Arg) (Genbank
accession no. JN628255; Fig. 2C), showing the two sequence
variations on separate homologs.
To determine if either mutation was inherited, maternal geno-
mic DNA from two independent blood samples was analyzed for
the presence of the nine-alanine expansion and the c.529G>C
point mutation identified in Patient 1, which showed that the
mother carried neither. While the mother could still be a low-level
somatic or germlinemosaic, neithermutated allele, nor any shorter
HOXA13 PCR products, were detected in repeated amplifications
of leukocyte derived DNA. A SNP-based haplotype upstream and
downstreamof theHOXA13 genewas constructed for Patient 1 and
her mother to determine the parental origin of the polyalanine
expansion. Patient 1’s HOXA13 SNP haplotype showed that the
polyalanine expansion must have originated de novo on the
maternal chromosome while the point mutation must have origi-
nated on the paternally inherited chromosome (Fig. 3).
To determine whether the polyalanine expansion occurred as a
result of unequal crossing-over between homologs during meiosis,
we used inverse PCR. Patient 1 was homozygous for the upstream
SNPs rs7812039 and rs13243033, whereas her mother was hetero-
zygous at these loci. Figure 3 also shows the results of inverse PCR
with maternal DNA. The de novo polyalanine expansion did not
arise by unequal crossing-over between maternal chromosome 7
homologs, and must have occurred as a result of either slipped
mispairing or unequal sister chromatid exchange in maternal mito-
sis prior to gamete production or during meiosis II, or by either
mechanism early on postzygotically. Although we did not examine
for mosaicism in Patient 1, a deleted product by PCR analysis was
never detected, suggesting that if the expansion had occurred
postzygotically, unequal sister chromatid exchange was unlikely.
Given that homozygous loss of Hoxa13 function is lethal
[Mortlock et al., 1996; Warot et al., 1997; Shaut et al., 2008],
andHOXA13 polyalanine tract expansions lead to a loss of function
[Innis et al., 2004], it is unlikely that Patient 1 would be compound
heterozygous for two disease-causing mutations. However, the
c.529G>C (p.Gly177Arg) point mutation found in Patient 1
has not been previously reported in dbSNP (build 135) or in the
NHLBI Exome Sequencing Project (snp.gs.washington.edu/EVS/)
and is therefore a very rare variant. Additionally, the glycine residue
at position 177 is highly conserved in HOXA13 among vertebrates
[Mortlock et al., 2000; Lehoczky and Innis, 2008] and lies within a
MEIS1 interacting domain [Williams et al., 2005]. Finally, arginine
(basic, hydrophilic) is not a conservative substitution for glycine
(small, neutral). Polyphen-2 analysis (genetics.bwh.harvard.edu/
pph2/) showed this substitution to be ‘‘probably damaging’’ with a
score of 0.992. Analysis of the c.529G>C point mutation using
Genomic Evolutionary Rate Profiling (GERP) [Cooper et al., 2005]
showed a rejected substitution score of 3.56, suggesting evolution-
ary selection against substitution at this nucleotide.
Therefore, to test the effect of this sequence variation on func-
tion, the p.Gly177Arg mutation was introduced into a plasmid
containing the mouse Hoxa13 cDNA through site-directed muta-
genesis and then the p.Gly177Arg HOXA13 transcriptional activa-
tion function was measured relative toWTHOXA13 on the EphA7
promoter in vitro. The EphA7 promoter is regulated in vivo by
Hoxa13 [Stadler et al., 2001]. As seen in Figure 4, the p.Gly177Arg
FIG. 1. Phenotype and pedigree of Patient 1. A: Limb phenotype in
Patient 1 with hand-foot-genital syndrome (HFGS). Note the short
thumbs and great toes with micronychia of the thumb and great
toe bilaterally (arrows). B: Pedigree of the patient’s family. Open
squares or circles mean the individual is unaffected. An asterisk
indicates individuals who were clinically examined.
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mutation did not significantly affect transcriptional activation by
HOXA13 in this in vitro assay (P¼ 0.631). This result does not
preclude an effect of this amino acid substitution on regulatory
activity at other target loci in different cellular contexts, but it
underscores the importance of functional analysis of sequence
variants. Also, if Patient 1’s father was heterozygous for the
p.Gly177Arg variant, these results would be consistent with absence
of paternal HFGS features.
Patient 2
The PCR analysis of large repeat tract III followed by cloning and
sequencing showedPatient 2 to carry one 6-alanine expansion allele
(c.358_375 dup18, inherited from his father) and a 10-alanine
contraction allele (c.355_384 del30, inherited from his asymptom-
atic mother and her asymptomatic father). Close examination of
Patient 2’s father showed a normal extremity exam (Fig. 5A,B),
suggesting either lack of penetrance or mosaicism. Paternal and
maternal HOXA13 PCR sequences matched Patient 2’s two alleles
(Fig. 5E,F). A SNP-based haplotype analysis upstream and down-
stream of HOXA13 was performed to identify the paternal chro-
mosome carrying the expanded alanine tract (Fig. 6). Both
unaffected siblings carried the same paternal allele as Patient 2
without the expanded alanine tract, suggesting that the father was
mosaic for the expansion. The PCR sequencing on the paternal
grandparents showed that neither were carriers, supporting the
hypothesis that Patient 2’s father sustained a postzygotic polyala-
nine expansion.
To provemosaicism and to distinguish unequal sister chromatid
exchange from slippedmispairing, a skin biopsy was obtained from
the father to look for WT, expanded, and contracted polyalanine
tract III alleles. One week later, after minimal expansion, the
fibroblasts were harvested, and a sample was plated into ten 96-
well plates at an average concentration of 0.8 cells per well. Many
wells showed no growth, but genomic DNA from 58 wells was
harvested and subjected toHOXA13PCR. TheDNA from11 clones
failed to amplify. Thirty-four clones had both an expansion allele
and a normal allele; 10 clones showed only amplification of the
normal sized allele. Thus, 34/44 clones (77%) showed expansion
and normal alleles, and 10/44 clones (23%) had normal alleles only,
by PCR. A separate cloning experiment performed later after
further expansion of the original culture, plated at higher density,
detected no contracted allele among 159 samples. An additional
paternal DNA sample derived from saliva showed only six-alanine
expansion allele and normal allele products by PCR.No shorter six-
alanine contraction allele product was observed in any genomic
PCR with paternal DNA from any tissue or with any of the clonal
fibroblast isolates.
FIG. 2. Polyalanine expansion and rare variant in Patient 1. A: The PCR and clone sequencing analysis of HOXA13 polyalanine tract III. Lane 1: Patient 1
PCR showing two products, one corresponding with the WT allele (arrow) and the other with the expansion. Lane 2: WT DNA. The PCR product visualized
adjacent to the marker lane was a separate control reaction. B: Sequencing of cloned expansion products in the patient showed a 27 bp
(nine-alanine) tandem duplication (c.357_383 dup27). Imperfect GCN triplets encoding alanine residues are depicted as shown; * nine-alanine
triplet codons duplicated in the expansion allele. C: Sequencing downstream of the polyalanine tract III showed a point mutation (c.529G> C,
p.Gly177Arg; Genbank accession no. JN628255) in the allele not carrying the polyalanine expansion. The WT sequence is shown on the left and the
asterisk indicates the mutated base in a PCR clone from the nonexpansion allele (c.529G> C).
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FIG. 3. Haplotypes of Family 1. Haplotype analysis of Patient 1 showed that the polyalanine expansion occurred on the maternally inherited allele,
while the p.Gly177Arg mutation originated on the paternally inherited allele. Diamond refers to inferred haplotypes. SNPs and hg19 reference
genomic positions are: rs7812039 (chr7:27,248,891), 9.2 kb centromeric (upstream) of the 50 end of HOXA13; rs13243033 (chr7:27248373),
8.7 kb centromeric of HOXA13; rs2189239 (chr7:27237453), 2.2 kb telomeric of the HOXA13 50 end; rs757181 (chr7:27236958), 2.7 kb
telomeric of the HOXA13 50 end; and rs2391397 (chr7:27236558), 3.1 kb telomeric of the HOXA13 50 end.
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DISCUSSION
Family 2 is the most informative regarding mechanism(s) for
HOXA13 polyalanine expansions. From four different sites
(blood, skin, saliva, andgonads by inheritance) and from individual
fibroblast clones of skin, only the expanded and normal allele sizes
were observed, supporting somatic and gonadal mosaicism in the
asymptomatic father of Patient 2. In addition, if the mechanism of
the expansionwasunequal crossingover between sister chromatids,
there should have been three different paternal cell lines: a six-
alanine expanded/WT, WT/WT and a six-alanine contracted/WT.
That no six-alanine contracted product was observed indicates that
either a cell line with a six-alanine contraction/WT genotype was
selected against in vivoor invitroor that themutationalmechanism
is not unequal sister chromatid exchange. The former explanation
seems veryunlikely given that a 10-alanine contraction allele is a low
frequency polymorphism in the normal population, and indeed
survives quite well in Patient 2, his mother, and maternal grandfa-
ther, making it difficult to argue that heterozygous loss of 6-alanine
residues would be deleterious. Thus, slipped mispairing appears
most likely as the mechanism of the postzygotic expansion in the
mosaic father. Unequal crossing-over between homologs [Warren,
1997; Brown and Brown, 2004], which is also theoretically possible
as amechanism of polyalanine expansion,was not supported by the
data from either of the patients described here.
Arai et al. [2007] proposed that unequal sister chromatid ex-
change may have led to de novo polyalanine expansions in the
PHOX2B gene in patients with congenital central hypoventilation
syndrome (CCHS; OMIM 209880); however, no data proving this
mechanism was presented. The authors proposed that this mecha-
nismcould account for the stability of thepolyalanine expansions as
well as the presence of normal contraction alleles. Contraction
alleles, although quite rare, have also been observed as presumably
normal variants in the HOXA13 gene [Brown and Brown, 2004;
Innis et al., 2004; Innis, 2006] and other genes with polyalanine
repeats. In Family 1, we observed nomosaicism for the polyalanine
expansion (and the expected reciprocal deleted product) in
either maternal or proband DNA. Failure to observe the deleted
product does not eliminate the possibility of either unequal sister
chromatid exchange or slipped mispairing occurring in the mater-
nal germline.
However, our data in Family 2 strongly support slipped mis-
pairing during replication as the mechanism for this instance of
HOXA13 polyalanine expansion. Slippedmispairing was previous-
ly proposed as a mechanism for the instability of repetitive DNA
tracts in yeast mutants for mismatch repair genes [Strand et al.,
1993]. Trochet et al. [2007] also presented a family where unequal
sister chromatid exchange was not a suitable explanation for a
PHOX2B polyalanine expansion in a mosaic (leukocyte DNA)
parent due to failure to detect a deleted product, and they proposed
that amispairing event without repair wasmore likely. Parodi et al.
[2008] also documented somatic mosaicism for PHOX2B expan-
sions, and did not identify shorter products expected for unequal
sister chromatid exchange in mosaic individuals. Additional poly-
alanine tract expansions involving at least twoduplications in single
alleles of HOXD13 and FOXL2 [Brown and Brown, 2004], also
support slipped mispairing. By replication slippage, both expan-
sions and contractions could occur, depending on whether tem-
plate or nascent strand misalignment was involved [Strand et al.,
1993; Chen et al., 2005; McMurray, 2010]. Finally, Cocquempot
et al. [2009] suggested FosTES (Fork stalling and TEmplate
Switching) [Lee et al., 2007] as the mechanism for polyalanine
expansion in the Hoxd13 gene in the mouse mutant Dyc, whose
structure is quite different from typical HOXA13 or HOXD13
polyalanine expansions. The authors stated that polyalanine tracts
contain microhomology, symmetry, and specific sequence motifs
that commonly lead to FosTES.
In our report, we have proven that slipped mispairing during
replicationmust have occurred in Family 2 and is possible in Family
1. Whereas paternal mosaicism in Family 2 indicates a postzygotic
origin for the expansion, the timing of expansion in Family 1 is
unclear. In addition, the 10-alanine contraction in Proband 2 was
inherited from the maternal grandfather. Thus, not unlike poly-
alanine expansions, this contraction has been stable in this family
through at least three generations. However, it would be intriguing
to examine formosaicismof contractions aswell, since an expanded
allele would be an expected product of unequal sister chromatid
exchange.
We reported on the molecular basis ofHypodactyly in mice, a 50
base pair deletion inHoxa13, and proposed that the deletion arose
from slipped mispairing or unequal crossing over catalyzed by
nearby 10 base pair GC-rich microhomology in the first exon of
Hoxa13 [Mortlock et al., 1996]. The location of human polyalanine
expansions as well as the Hypodactyly deletion in HOXA13 exon 1
associated with numerous GC-rich microhomologies supports the
hypothesis that the structure predisposes to expansions, contrac-
tions, and deletions of several types depending on the nature of the
mispairing event.
Finally, other than for PHOX2B [Parodi et al., 2008; Trochet
et al., 2007], this is the third investigation of mosaic polyalanine
expansion carriers documenting results consistent with slipped
FIG. 4. In vitro transcriptional activation function of p.Gly177Arg
HOXA13 on the EphA7 promoter. Percent luciferase activities
(relative to wt control) are indicated on the y-axis. HOXA13 wt or
G177R (normalized to Renilla and empty vector controls) are
plotted on the x-axis. Results are the mean SD of three separate
experiments.
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mispairing. In contrast, despite the possibility of unequal sister
chromatid exchange or homologous recombination generating
polyalanine expansions, there has been no report of a proven
occurrence. It will be important to identify mosaic individuals
for other polyalanine expansion disorders, and possibly for con-
tractions, and investigate particularly by clonal analysis whether
replication slippage is the predominant mechanism or not.
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FIG. 5. Phenotype and polyalanine repeat size in Family 2. A,B: Hands and feet of asymptomatic father of Patient 2. C,D: Hands and feet of Patient 2
demonstrating typical HFGS skeletal features. E: HOXA13 PCR products across large repeat III in Family 2. Lane 1, asymptomatic father (6-alanine
expansion (c.358_375 dup18)/WT alleles); lane 2, asymptomatic mother (10-alanine contraction (c.355_384 del30)/WT); lane 3, Patient 2 (6-
alanine expansion/10-alanine contraction); lanes 4,5, asymptomatic sister and brother (WT/WT); lane 6, normal control; lane 7, water control. F:
Imperfect GCX triplets encoding alanine residues are depicted as shown; * six-alanine triplet codons duplicated in the expansion allele. The
contraction allele sequence of triplet codons inherited from the maternal grandfather is shown.
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FIG. 6. Pedigree and haplotypes of Family 2. Patient 2 with HFGS, filled in square. Dotted line: father of proband is mosaic for HOXA13 polyalanine
expansion/WT and WT/WT allele-bearing cells. Patient 2 inherited a 10-alanine contraction (instead of 18 alanines, this allele has 8-alanine residues
in tract III) from his asymptomatic mother. All individuals with an * were examined. Asymptomatic siblings of Patient 2 inherited the same
chromosome haplotype from their father, without the polyalanine expansion observed in Patient 2.
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